U.S. flag

An official website of the United States government

Drug Utilization Review Annual Report

On an annual basis, states are required to report on their practitioners prescribing habits, cost savings generated from their Drug Utilization Review (DUR) programs and their program’s operations, including adoption of new innovative DUR practices via the Medicaid Drug Utilization Review Annual Report Survey. Please visit the Drug Utilization Review page for more information.

For an overview of Medicaid Prescription Drug Programs visit the Prescription Drugs page.

Fee-for-Service (FFS) National State Drug Utilization Review (DUR) Annual Reports

Year Type Title
2020 FSS National State Report (PDF, 7.18 MB)
2019 FFS National State Report (PDF, 23.15 MB)
2018 FFS National State Report (PDF, 4.02 MB)
2017 FFS National State Report (PDF, 1.03 MB)
2016 FFS National State Report (PDF, 830.38 KB)
2015 FFS National State Report (PDF, 841.05 KB)
2014 FFS National State Report (PDF, 1.22 MB)
2013 FFS National State Report (PDF, 702.18 KB)
2012 FFS National State Report (PDF, 337.68 KB)

Fee-for-Service (FFS) State Drug Utilization Review (DUR) Annual Reports

To request 2017 FFS state reports and attachments, including attachments related to the state reports in the table below, please contact the DUR resource mailbox, CMSDUR@cms.hhs.gov.

Year State Full Name Title
Year State Full Name Title

Managed Care Organization (MCO) National State Drug Utilization Review (DUR) Annual Reports

Year Type Title
2020 MCO National State Report (PDF, 3.32 MB)
2019 MCO National State Report (PDF, 8.5 MB)
2018 MCO National State Report (PDF, 4.61 MB)

Managed Care Organization (MCO) State Drug Utilization Review (DUR) Annual Reports

Year State Title
Year State Title

Managed Care Organization (MCO) Drugs Outside of Capitation State Drug Utilization Review (DUR) Annual Reports

Year State Title
Year State Title

42 CFR Subpart K – Drug Use Review (DUR) Program and Electronic Claims Management System for Outpatient Drug Claims Section 456.700-456.725 provides the requirements for the DUR program. 

Please direct all communications to the CMSDUR@cms.hhs.gov resource mailbox.

Disclaimer: Please note that the information provided on this web page does not bind or obligate the Centers for Medicare and Medicaid Services (CMS). The statements included on this web page are intended to provide information on CMS Medicaid Drug Utilization Review and do not in any way revise or modify the requirements set forth in Section 1927 of the Act, regulations or program releases.

Page last updated on December 3, 2021